Aspira Women's Health Reports Officer and Director Changes
Ticker: AWHL · Form: 8-K · Filed: Mar 19, 2025 · CIK: 926617
Sentiment: neutral
Topics: leadership-change, officer-appointment, director-election, compensation
Related Tickers: AWH
TL;DR
Aspira Women's Health (AWH) filed an 8-K for leadership and compensation changes effective March 15.
AI Summary
Aspira Women's Health Inc. filed an 8-K on March 19, 2025, reporting changes as of March 15, 2025. The filing pertains to the departure of directors or certain officers, the election of directors, and the appointment of certain officers, as well as compensatory arrangements for certain officers. Specific details regarding the individuals involved, their roles, and the nature of the compensatory arrangements are expected to be elaborated within the filing's exhibits.
Why It Matters
Changes in key leadership and officer compensation can signal shifts in company strategy, operational focus, or financial health, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in directors and officers, especially if related to compensation, can indicate internal shifts that may affect the company's direction and stability.
Key Players & Entities
- Aspira Women's Health Inc. (company) — Registrant
- March 15, 2025 (date) — Effective date of reported changes
- March 19, 2025 (date) — Filing date of the 8-K
FAQ
What specific officer positions were affected by the changes reported in the 8-K?
The filing indicates the appointment of certain officers, but the specific positions are detailed in the exhibits.
Were there any director departures or new director elections?
Yes, the filing explicitly mentions the departure of directors or certain officers and the election of directors.
What is the effective date of the reported changes?
The earliest event reported is dated March 15, 2025.
Does the filing detail the compensatory arrangements for the officers?
Yes, the filing covers compensatory arrangements of certain officers, with specifics likely found in the accompanying exhibits.
What is the SIC code for Aspira Women's Health Inc.?
The Standard Industrial Classification (SIC) code for Aspira Women's Health Inc. is 2835, which corresponds to IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 19, 2025 regarding Aspira Women's Health Inc. (AWHL).